Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum.

Obaldia N 3rd, Kotecka BM, Edstein MD, Haynes RK, Fugmann B, Kyle DE, Rieckmann KH.

Antimicrob Agents Chemother. 2009 Aug;53(8):3592-4. doi: 10.1128/AAC.00471-09. Epub 2009 Jun 8.

2.

First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.

Nagelschmitz J, Voith B, Wensing G, Roemer A, Fugmann B, Haynes RK, Kotecka BM, Rieckmann KH, Edstein MD.

Antimicrob Agents Chemother. 2008 Sep;52(9):3085-91. doi: 10.1128/AAC.01585-07. Epub 2008 Jun 16.

3.

Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate--JPC2056--in cynomolgus monkeys using an in vivo in vitro model.

Edstein MD, Kotecka BM, Ager AL, Smith KS, DiTusa CA, Diaz DS, Kyle DE, Schiehser GA, Jacobus DP, Rieckmann KH, O'Neil MT.

J Antimicrob Chemother. 2007 Oct;60(4):811-8. Epub 2007 Jul 23.

PMID:
17646199
4.

Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.

Edstein MD, Kotecka BM, Anderson KL, Pombo DJ, Kyle DE, Rieckmann KH, Good MF.

Antimicrob Agents Chemother. 2005 Oct;49(10):4421-2. No abstract available.

5.

Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma.

Kotecka BM, Rieckmann KH, Davis TM, Batty KT, Ilett KF.

Acta Trop. 2003 Aug;87(3):371-5.

PMID:
12875931
6.

Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic.

Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, Sattabongkot J.

Antimicrob Agents Chemother. 2003 Jan;47(1):170-3.

7.

Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials.

Jensen NP, Ager AL, Bliss RA, Canfield CJ, Kotecka BM, Rieckmann KH, Terpinski J, Jacobus DP.

J Med Chem. 2001 Nov 8;44(23):3925-31.

PMID:
11689078
8.

Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides.

Strekowski L, Zegrocka O, Henary M, Say M, Mokrosz MJ, Kotecka BM, Manzel L, Macfarlane DE.

Bioorg Med Chem Lett. 1999 Jul 5;9(13):1819-24.

PMID:
10406648
9.

Plasma chloroquine concentrations in young and older malaria patients treated with chloroquine.

Maitland K, Williams TN, Kotecka BM, Edstein MD, Rieckmann KH.

Acta Trop. 1997 Sep 10;66(3):155-61.

PMID:
9210966
10.

New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine.

Kotecka BM, Barlin GB, Edstein MD, Rieckmann KH.

Antimicrob Agents Chemother. 1997 Jun;41(6):1369-74.

11.

Chloroquine bioassay of plasma specimens obtained from soldiers on chloroquine plus doxycycline for malaria prophylaxis.

Kotecka BM, Edstein MD, Rieckmann KH.

Int J Parasitol. 1996 Nov;26(11):1325-9.

PMID:
9024880
12.

In vivo-in vitro model to assess chloroquine activity in monkeys.

Kotecka BM, Rieckmann KH.

Chemotherapy. 1995 Mar-Apr;41(2):134-40.

PMID:
7758357
13.

Chloroquine bioassay using malaria microcultures.

Kotecka BM, Rieckmann KH.

Am J Trop Med Hyg. 1993 Oct;49(4):460-4.

PMID:
8214275

Supplemental Content

Loading ...
Support Center